Palatin Technologies Inc
PTN
NASDAQ
Biotechnology
$9.36
USD
-0.64 (-6.40%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $18.30M
Volume 12.3K
Revenue
$12.88M
TTM
+3581.2%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-6.25M
TTM
+73.2%
YoY
Operating Cash Flow
$-14.93M
TTM
+37.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 8.8 | 0.1 | 3.9 |
YoY Growth | — | -100.0% | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 8.8 | 0.1 | 3.9 |
Selling, General & Administrative | 1.5 | 2.6 | 1.7 | 3.1 | 2.0 |
Other Operating Expenses | -0.4 | 0.4 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 4.8 | 5.0 | 4.2 | 7.4 | 5.5 |
Operating Income | -4.8 | -5.0 | 4.7 | -7.3 | -1.6 |
EBITDA | -4.8 | -5.0 | 4.7 | -7.3 | -1.6 |
Other Income / Expense | -0.0 | 2.8 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | 0.0 | 2.8 | 0.0 | 0.1 | 0.1 |
Income Before Income Taxes | -4.8 | -2.2 | 4.7 | -7.3 | -1.4 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -4.8 | -2.2 | 4.7 | -7.3 | -1.4 |
Consolidated Net Income / Loss | -4.8 | -2.2 | 4.7 | -7.3 | -1.4 |
Net Income Attributable to Common Shareholders | -4.8 | -2.2 | 4.7 | -7.3 | -1.4 |
Basic EPS | -$9.13 | -$2.73 | $4.81 | -$2.86 | -$0.37 |
Diluted EPS | -$9.13 | -$2.73 | $4.26 | -$2.86 | -$0.37 |
Basic Shares Outstanding | 0.5M | 0.8M | 1.0M | 2.5M | 3.9M |
Diluted Shares Outstanding | 0.5M | 0.8M | 1.1M | 2.5M | 3.9M |